367 related articles for article (PubMed ID: 34890492)
21. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
[TBL] [Abstract][Full Text] [Related]
22. Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters.
O'Donnell KL; Clancy CS; Griffin AJ; Shifflett K; Gourdine T; Thomas T; Long CM; Furuyama W; Marzi A
Front Immunol; 2021; 12():788235. PubMed ID: 35069564
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 omicron variant: Could it be another threat?
Shanmugaraj B; Malla A; Khorattanakulchai N; Phoolcharoen W
J Med Virol; 2022 Apr; 94(4):1284-1288. PubMed ID: 34927270
[No Abstract] [Full Text] [Related]
24. Coronavirus Disease 2019 Vaccine Development: An Overview.
Sumirtanurdin R; Barliana MI
Viral Immunol; 2021 Apr; 34(3):134-144. PubMed ID: 32985963
[TBL] [Abstract][Full Text] [Related]
25. A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.
Pishesha N; Harmand TJ; Rothlauf PW; Praest P; Alexander RK; van den Doel R; Liebeskind MJ; Vakaki MA; McCaul N; Wijne C; Verhaar E; Pinney W; Heston H; Bloyet LM; Pontelli MC; Ilagan MXG; Jan Lebbink R; Buchser WJ; Wiertz EJHJ; Whelan SPJ; Ploegh HL
Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34654739
[TBL] [Abstract][Full Text] [Related]
26. Omicron: Call for updated vaccines.
Li X
J Med Virol; 2022 Apr; 94(4):1261-1263. PubMed ID: 34927258
[TBL] [Abstract][Full Text] [Related]
27. How to redesign COVID vaccines so they protect against variants.
Callaway E; Ledford H
Nature; 2021 Feb; 590(7844):15-16. PubMed ID: 33514888
[No Abstract] [Full Text] [Related]
28. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era.
Volkan E
Mol Biotechnol; 2021 Oct; 63(10):885-897. PubMed ID: 34145550
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 vaccinations: The unknowns, challenges, and hopes.
Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
[TBL] [Abstract][Full Text] [Related]
30. Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies.
Nawaz S; Janiad S; Fatima A; Saleem M; Fatima U; Ali A
Infect Disord Drug Targets; 2024; 24(4):58-66. PubMed ID: 38178666
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants.
Abdi Ghavidel A; Rojhannezhad M; Kazemi B; Bandehpour M
Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):647-671. PubMed ID: 34920649
[TBL] [Abstract][Full Text] [Related]
32. Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies.
Bian L; Gao F; Zhang J; He Q; Mao Q; Xu M; Liang Z
Expert Rev Vaccines; 2021 Apr; 20(4):365-373. PubMed ID: 33851875
[TBL] [Abstract][Full Text] [Related]
33. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
34. The challenge of emerging SARS-CoV-2 mutants to vaccine development.
Li R; Liu J; Zhang H
J Genet Genomics; 2021 Feb; 48(2):102-106. PubMed ID: 33994322
[No Abstract] [Full Text] [Related]
35. Novavax offers first evidence that COVID vaccines protect people against variants.
Callaway E; Mallapaty S
Nature; 2021 Feb; 590(7844):17. PubMed ID: 33510489
[No Abstract] [Full Text] [Related]
36. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.
Narowski TM; Raphel K; Adams LE; Huang J; Vielot NA; Jadi R; de Silva AM; Baric RS; Lafleur JE; Premkumar L
Cell Rep; 2022 Feb; 38(5):110336. PubMed ID: 35090596
[TBL] [Abstract][Full Text] [Related]
37. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
Front Immunol; 2021; 12():800723. PubMed ID: 34992610
[TBL] [Abstract][Full Text] [Related]
38. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z
Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381
[TBL] [Abstract][Full Text] [Related]
39. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.
Boyarsky BJ; Chiang TP; Ou MT; Werbel WA; Massie AB; Segev DL; Garonzik-Wang JM
Transplantation; 2021 Aug; 105(8):e82-e83. PubMed ID: 34098566
[No Abstract] [Full Text] [Related]
40. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
Groves DC; Rowland-Jones SL; Angyal A
Biochem Biophys Res Commun; 2021 Jan; 538():104-107. PubMed ID: 33199022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
